UPDATE : Friday, August 17, 2018
상단여백
Will biotech stocks rebound on listings in H2?
The biotech industry is paying attention to whether upcoming initial public...
by So Jae-hyeon  |  2018-05-30 11:33
라인
Samsung BioLogics wins FDA nod for drug manufacturing procedure
Samsung BioLogics said Thursday that it has received approval for a drug su...
by Lee Han-soo  |  2018-05-24 15:56
라인
7 Korean biopharma firms dive into biosimilar market
Korea’s “bio fever” is being spurred on by the domestic development of bios...
by Marian Chu  |  2018-05-19 08:19
라인
Celltrion posts ￦245 billion in Q1 sales thanks to biosimilar uptake
Celltrion recorded sales of 245 billion won ($227 million) in the first qua...
by Marian Chu  |  2018-05-16 12:13
라인
Will Korean bio stocks rebound as MSCI includes Celltrion, Viromed, HLB?
Although the stocks of Korean biopharmaceutical companies plummeted followi...
by Marian Chu  |  2018-05-16 11:25
라인
Korean biosimilar companies welcome US pro-biosimilar initiative
Korean biosimilar companies, such as Celltrion welcomed U.S. President Dona...
by Lee Han-soo  |  2018-05-15 17:07
라인
Biotech shares weaken on KONEX, too
As biotech stocks on KOSPI and KOSDAQ have turned downward since mid-April,...
by Nam Doo-hyun  |  2018-05-15 14:02
라인
Large pool of capital available in biotech space: US venture fund expert
American venture capital firms like Mountain Pacific have raised a record a...
by Marian Chu  |  2018-05-11 18:10
라인
HAFS students win grand prize in KHIDI Bio Startup Contest
Three students from Hankuk Academy of Foreign Studies took the grand prize ...
by Marian Chu  |  2018-05-11 14:32
라인
Samsung BioLogics shares recover despite window dressing controversy
Biotech and pharmaceutical shares are bouncing back from recent massive sli...
by Nam Doo-hyun  |  2018-05-10 11:08
라인
Bio & Medical Korea 2018 kicks off
Bio Korea 2018 and Medical Korea 2018 kicked off for a three-day run in COE...
by Lee Han-soo  |  2018-05-09 11:55
라인
Va-Q-Tec to up investment in Korean biopharmaceuticals
Germany’s logistics and packaging company Va-Q-Tec said it would significan...
by Nam Doo-hyun  |  2018-05-09 11:54
라인
Pharma, biotech shares tank amid Samsung BioLogics debacle
Pharmaceutical and biotech shares are suffering a massive blow from repercu...
by Nam Doo-hyun  |  2018-05-08 11:20
라인
Celltrion launches third biosimilar in EU
Celltrion Healthcare said Thursday that it has started marketing Herzuma (O...
by Lee Han-soo  |  2018-05-04 17:21
라인
Samsung BioLogics denies accounting irregularities
Shim Byung-hwa (left), Samsung BioLogics’ business innovation team leader, ...
by Lee Han-soo  |  2018-05-02 17:12
라인
VC investment in biomedicine rises 200% y-o-y in Q1
New venture capital investment in the biomedical industry rose more than 20...
by Nam Doo-hyun  |  2018-04-30 14:14
라인
Chong Kun Dang wins US patent for anemia biosimilar
Chong Kun Dang said Friday that it has acquired a patent regarding the form...
by Lee Han-soo  |  2018-04-27 15:39
라인
Hugel posts ￦45.8 billion in Q1 sales
Hugel said Tuesday that it recorded 45.8 billion won ($42.3 million) in the...
by Lee Han-soo  |  2018-04-26 12:51
라인
Samsung BioLogics posts ￦131 billion in Q1 sales
Samsung BioLogics said Tuesday that it recorded 131 billion won ($121.1 mil...
by Lee Han-soo  |  2018-04-25 17:47
라인
Pharma shares on the rise since early this year
Pharmaceutical and biotech shares have recently suffered declines, but most...
by Nam Doo-hyun  |  2018-04-25 13:56
-12345678910-
Biotech firms grudge over regulator’s plan to toughen disclosure rulesBiotech firms grudge over regulator’s plan to toughen disclosure rules
여백
Most viewed
여백
Opinion
[Reporter’s Notebook] Is Korean market unimportant for Samsung Bioepis?
[Reporter’s Notebook] Is Korean market unimportant for Samsung Bioepis?
[Column] Buy expensive and waste your money?
[Column] Buy expensive and waste your money?
[Reporter’s Notebook] Korean medical workers living in fear of violence
[Reporter’s Notebook] Korean medical workers living in fear of violence
여백
Back to Top